ADIM
BIIB icon

Alpha DNA Investment Management’s Biogen BIIB Stock Holding History

Alpha DNA Investment Management’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-3,663
Closed -$978K – 153
2022
Q3 		$978K Buy
+3,663
New +$778K 0.81% 35

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Alpha DNA Investment Management's BIIB Position: Q4 2022 in Review

Alpha DNA Investment Management sold out of Biogen (BIIB) in Q4 2022, closing a stake of 3,663 shares — an estimated $978K sold.

Alpha DNA Investment Management first reported a position in BIIB in Q3 2022 and held it in 1 quarter. The position peaked at $978K in Q3 2022. 1,031 funds tracked by Wall St. Rank hold BIIB as of Q4 2022.

  • Alpha DNA Investment Management reported no remaining Biogen position as of Q4 2022 after selling out during the quarter.
  • Alpha DNA Investment Management sold 3,663 Biogen shares in Q4 2022, an estimated $978K.
  • Alpha DNA Investment Management first reported a position in Biogen in Q3 2022 and held it in 1 quarter.
  • Alpha DNA Investment Management's Biogen position peaked at $978K in Q3 2022.
  • 1,031 funds tracked by Wall St. Rank held Biogen as of Q4 2022.

Based on Alpha DNA Investment Management's 13F filing for Q4 2022, filed 27 Jan 2023.